For the past two months, we focused on US Healthcare and the European Healthcare systems. This month we are explored China’s Healthcare system by diving deep into the intricacies of government schemes, regulatory reforms, and trends and practices. In 2023, China spent around 5.4% of its GDP to boost healthcare services across its provinces.
In PharmaShots’ Health Innovation report of 2024, China ranked 9th with an overall score of 26 out of 40. China emerged as a global leader in the pharmaceutical industry and holds a second position in the global pharmaceutical market. Get ready to explore the Chinese Healthcare System like never before with engaging articles, illustrative infographics, trailing BioTrends, illuminating regulatory updates, and a few amazing facts to keep you hooked throughout the magazine.
In February, PharmaShots will be exploring Japan’s Healthcare system and the theme for March Edition revolves around CDMOs.
Get a chance to advertise with us for free! Share your promotional pieces, white papers, and interviews on connect@pharmashots.com
